TipRanks
Immunovant (DE:4YB)
STUTTGART:4YB

Compare Immunovant (4YB) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
―
€5.38B
-10.34
8 Buy
3 Hold
0 Sell
Moderate Buy
TG Therapeutics
$55.42
$9.36B
20.09
79.84%
4 Buy
0 Hold
1 Sell
Moderate Buy
Viridian Therapeutics
$24.18
$2.79B
-6.99
4.27%
12 Buy
0 Hold
0 Sell
Strong Buy
Aurinia Pharmaceuticals
$16.75
$2.22B
7.03
37.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
Protagonist Therapeutics
$150.59
$9.37B
118.91
86.06%
13 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$125.55
$10.81B
-34.88
106.10%
15 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4YB
Immunovant
―
―
―
TGTX
TG Therapeutics
61.18
26.40
75.91%
VRDN
Viridian Therapeutics
24.67
1.04
4.40%
AUPH
Aurinia Pharmaceuticals
16.65
3.48
26.42%
PTGX
Protagonist Therapeutics
144.85
66.23
84.24%
KYMR
Kymera Therapeutics
126.63
64.79
104.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts